Artelo Biosciences (ARTL) 2022 Investor Presentation

Artelo Biosciences is a clinical-stage biopharmaceutical company developing a portfolio of therapeutic lipid-modification candidates targeting significant unmet needs in cancer and other serious diseases. The company features a novel drug pipeline, proven leadership, and robust patent estate with near-term milestones in billion-dollar markets.